4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015325
Chief Financial Officer sold 2,215 shares at $57.22 ($126,742)
- Chief Financial Officer acquired 6,600 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-02-16 | Option exercise 10b5-1 | +6,600 | 112,144 | D | ||
| Smith Hunter C Chief Financial Officer | 2025-02-19 | Sale 10b5-1 | −2,215 | $57.22 | $126,742 | 109,929 | D |
| Derivatives | |||||||
| Smith Hunter C Chief Financial Officer | 2025-02-14 | Grant or award · Restricted Stock Units 10b5-1 | +41,650 | 41,650 | D | ||
| Smith Hunter C Chief Financial Officer | 2025-02-14 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +62,500 | 62,500 | D | ||
| Smith Hunter C Chief Financial Officer | 2025-02-16 | Option exercise · Restricted Stock Units 10b5-1 | −6,600 | 19,800 | D | ||
| Open-market sales · 2,215 sh · avg $57.22 · $126,742 | |||||||
Loading xslF345X05/tm257103-8_4seq1.xml…